Recent News

• 04.21.2025 - Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
• 04.01.2025 - Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey
• 02.04.2025 - Milestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical LLC
• 01.23.2025 - Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon
• 12.04.2024 - Milestone Scientific to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference on December 11th, 2024
• 11.26.2024 - Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System
• 11.14.2024 - Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024
• 11.14.2024 - Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO
• 11.12.2024 - Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
• 11.12.2024 - Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call

Recent Filings

• 04.15.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.28.2025 - NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
• 02.07.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 01.13.2025 - 8-K Current report
• 12.20.2024 - 4 Statement of changes in beneficial ownership of securities
• 12.20.2024 - 8-K Current report
• 12.19.2024 - 144 Report of proposed sale of securities
• 11.14.2024 - EX-99.1 EX-99.1
• 11.14.2024 - 8-K Current report
• 11.14.2024 - 10-Q Quarterly report [Sections 13 or 15(d)]